The biggest reward of Amgen's early genome work, however, may be the osteoporosis drug dubbed AMG 162, based on the bone gene that Amgen lab coats were so surprised to discover in fetal rat intestines in 1995.

FORBES: Companies, People, Ideas

Amgen researchers stumbled on the OPG gene a decade ago when they found a version of it, oddly enough, in the intestines of rat fetuses.

FORBES: Biotech Behemoth